Found: 1
Select item for more details and to access through your institution.
Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus-infected patients: Long-term follow-up results from the open-label, Phase II IMPACT study.
- Published in:
- Health Science Reports, 2020, v. 3, n. 2, p. 1, doi. 10.1002/hsr2.145
- By:
- Publication type:
- Article